
Synergy Shield Coronary Stent 2.50 X 8 | REF H7493966608250
Boston Scientific Synergy Shield Coronary Stent, 2.50 mm x 8 mm (REF H7493966608250) for B2B medical device procurement.

The Terumo Ultimaster Nagomi Coronary Stent (REF DE-RS3021ASM) is a sirolimus-eluting coronary stent system designed for percutaneous coronary intervention. This 3.00 mm x 21 mm configuration is mounted on a rapid exchange delivery catheter intended to support navigation through the coronary vasculature and controlled deployment at the target lesion.
Key Features
Thin-strut cobalt-chromium stent platform engineered for deliverability and conformability
Sirolimus drug coating with a bioresorbable polymer matrix applied to the abluminal surface
Rapid exchange (monorail) delivery system for single-operator handling
Nominal stent diameter 3.00 mm and nominal stent length 21 mm
Radiopaque balloon markers intended to assist fluoroscopic positioning
Clinical Applications
Intended for use in the coronary arteries as part of percutaneous coronary intervention procedures
Supports treatment planning for de novo coronary artery lesions in vessels compatible with the 3.00 mm nominal diameter
Suitable for catheterization laboratory inventories requiring mid-length drug-eluting stent options
Refer to the manufacturer Instructions for Use for indications, contraindications, warnings, and full clinical guidance
Product Information
Brand: Terumo
Product Line: Ultimaster Nagomi
Category: Coronary Stents
REF / UPN: DE-RS3021ASM
Stent Diameter: 3.00 mm
Stent Length: 21 mm
Drug Coating: Sirolimus with bioresorbable polymer
Delivery System: Rapid exchange
Stent Material: Cobalt-chromium alloy
Guide Wire Compatibility: Not specified in the located sources
Guiding Catheter Compatibility: Not specified in the located sources
Sterility: Supplied sterile for single use
Storage: Per manufacturer labeling
Tell us what product you need and share a few details.
We connect your request with the most relevant verified brands.
Relevant supplier options can respond with availability, documentation context, and quote details.
Practical answers for procurement teams reviewing this product page.
Include the exact product family, brand preference, REF/UPN code when available, required quantity, destination country, expected delivery timing and documentation expectations.
Yes. If alternatives are acceptable, mention equivalent brands, compatible models, size ranges and any non-negotiable requirements.
Related products are connected through structured catalog data such as brand, category, product family and country assignment.
No. This page supports sourcing and RFQ organization. Buyers must verify regulatory status, clinical suitability and procurement compliance independently.
Specific codes reduce ambiguity and help supplier teams identify product availability, packaging details and documentation faster.
Yes. The workflow is designed for hospitals, clinics, distributors, wholesalers, importers and procurement departments.
Yes. Products can be connected to multiple countries in the admin panel, and buyers can specify destination details in the RFQ form.
The request is stored with contact and procurement details so the sourcing conversation can be reviewed and followed up clearly.